Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Corporate Headquarters: , 235 E. 42nd Street, New York, NY, 10017, US
Pfizer CentreOne is an award-winning contract manufacturing organization (CMO) dedicated to maximizing your product’s potential. Powered by Pfizer's technical expertise and global network, we offer commercial manufacturing for oral solids, sterile injectables and biologics—delivering scale, quality and process excellence. Because time is life.
Insight on market dynamics driving OSD forms, key development and manufacturing challenges, and the specialized capabilities needed to address them.
Released By Pfizer CentreOne
Vice President and General Manager of Pfizer CentreOne talks with Ben Locwin about drug development trends and challenges and Pfizer’s lightspeed approach.
Global Head of Strategic Account Management for Pfizer CentreOne talks with host Ben Locwin about the advantages of working with an integrated CDMO.
Sterile injectables play a pivotal role in delivering crucial medications, including antibiotics, vaccines, and biologics, directly into the bloodstream.
An influx of innovative molecules pose formulation development challenges due to absorption and bioavailability issues.
This whitepaper looks at the broad set of trends influencing pharmaceutical development and manufacturing strategy today.
The approval covers the LP.8.1-adapted vaccine, designed to address evolving SARS-CoV-2 sublineages.
By: Charlie Sternberg
Makes targeted investments and builds new partnerships in the APAC region.
CureVac and GSK will receive $740 million and single-digit royalties on COVID-19 vaccine sales in the U.S. going forward.
These three executives will support Hansa’s growth and further enhance the company’s expertise across legal, human resources, and corporate affairs.
Dr. Cristian Massacesi will oversee the company’s early-stage and late-stage product development across all therapeutic areas.
Gains exclusive rights for the development, manufacturing and commercialization of 3SBio’s SSGJ-707.
A look at the shifting strategies and surging sectors reshaping the Top 20 drugmakers.
By: Tim Wright
Tracking industry leaders by Rx sales and strategic shifts.
Kane will advance strategic priorities and advance Solrikitug, its lead asset, in Phase II trials and prepare for Phase III.
By: Rachel Klemovitch
New appointments to the leadership team also include Stefan Larson as Chair of the Board of Directors and Ingmar Bruns as a new Board Member.
Establishes a strategic partnership with DHL Group aimed at enhancing supply chain service offerings.
SSGJ-707 has shown initial efficacy and safety data in a promising class of cancer medicines.
Sumant Ramachandra succeeds Co-Founder Noa Shelach, who remains with the company as COO.
Pact supports further expansion of pridopidine in Huntington’s disease, amyotrophic lateral sclerosis and future indications.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
